Iloperidone, asenapine and lurasidone: a primer on their current status

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.13, 2012-09, pp. : 1911-1922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-Analysis

By > Yu Weiping Detraux Johan Sweers Kim > Correll Christoph U.

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 733-759

Adis International

Access to resources Recommend Favorite

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 681-691

Bentham Science Publishers

Access to resources Recommend Favorite

Current Trends on Antipsychotics: Focus on Asenapine

Current Medicinal Chemistry, Vol. 23, Iss. 21, 2016-08 ,pp. : 2204-2216

Bentham Science Publishers

Access to resources Recommend Favorite

Asenapine

By Weber Juliane McCormack Paul L.

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 781-792

Adis International

Access to resources Recommend Favorite

Iloperidone for schizophrenia

By Rado Jeffrey Janicak Philip G

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2087-2093

Informa Healthcare

Access to resources Recommend Favorite